Healthcare >> CEO Interviews >> October 12, 2001
DR. LOUIS G. LANGE was a Founder of CV Therapeutics Inc. and has served
as the Chairman of the Board and Chief Executive Officer since August
1992. From July 1980 to August 1992, Dr. Lange served on the faculty of
Washington University School of Medicine, including serving as Chief of
Cardiology at Jewish Hospital in St. Louis, Missouri, from May 1985 to
August 1992, and as a full Professor of Medicine from July 1990 until
August 1992. Dr. Lange is internationally recognized as an expert in the
field of molecular mechanisms of cardiovascular disease. He holds an MD
from Harvard Medical School and a PhD in Biochemistry from Harvard
University. He was recently on the Board of Directors of Cardiac
Pathways Corporation and is currently on the Board of Directors, the
Executive Committee and is Chair of the Health Affairs Committee at the
University of Rochester. He also serves on the Executive Committee of
the Biotechnology Industry Organization, as well as the BIO Board of
Directors and the Emerging Companies Governing Section. He was recently
appointed to the Board of TIMI-3. Profile
Therapeutics is?
Dr. Lange: What CV Therapeutics has, as you know, as its mission is to
be a leader in the discovery,
